Page 1 | Search Results | Hematology, ASH Education Program

1-9 of 9

Sort by

Sort Order Select

Journal Articles

Immunoregulatory networks in sickle cell alloimmunization

Karina Yazdanbakhsh

Hematology Am Soc Hematol Educ Program (2016) 2016 (1): 457–461.

https://doi.org/10.1182/asheducation-2016.1.457

Published: 2016

Journal Articles

Should the presence of an antiphospholipid antibody affect the duration of anticoagulant treatment in patients with venous thromboembolism?

David A. Garcia, Wendy Lim

Hematology Am Soc Hematol Educ Program (2013) 2013 (1): 681–683.

https://doi.org/10.1182/asheducation-2013.1.681

Published: 2013

Journal Articles

Role of ADAMTS13 in the pathogenesis, diagnosis, and treatment of thrombotic thrombocytopenic purpura

Johanna A. Kremer Hovinga, Bernhard Lämmle

Hematology Am Soc Hematol Educ Program (2012) 2012 (1): 610–616.

https://doi.org/10.1182/asheducation.V2012.1.610.3798654

Published: 2012

Journal Articles

The many faces of common variable immunodeficiency

Charlotte Cunningham-Rundles

Hematology Am Soc Hematol Educ Program (2012) 2012 (1): 301–305.

https://doi.org/10.1182/asheducation.V2012.1.301.3798316

Published: 2012

Journal Articles

What is the Benefit of Maintenance Therapy with Lenalidomide or Bortezomib after Autologous Stem Cell Transplantation in Multiple Myeloma and What is the Risk of Developing a Secondary Primary Malignancy?

Emma Scott, Donna Reece

Hematology Am Soc Hematol Educ Program (2011) 2011 (1): 205–207.

https://doi.org/10.1182/asheducation-2011.1.205

Published: 2011

Journal Articles

ASH evidence-based guidelines: is the IgG-specific anti-PF4/heparin ELISA superior to the polyspecific ELISA in the laboratory diagnosis of HIT?

Adam Cuker, Thomas L. Ortel

Hematology Am Soc Hematol Educ Program (2009) 2009 (1): 250–252.

https://doi.org/10.1182/asheducation-2009.1.250

Published: 2009

Journal Articles

Mechanisms of anti-D action in the prevention of hemolytic disease of the fetus and newborn

Davor Brinc, Alan H. Lazarus

Hematology Am Soc Hematol Educ Program (2009) 2009 (1): 185–191.

https://doi.org/10.1182/asheducation-2009.1.185

Published: 2009

Journal Articles

Drug-induced immune hemolytic anemia

George Garratty

Hematology Am Soc Hematol Educ Program (2009) 2009 (1): 73–79.

https://doi.org/10.1182/asheducation-2009.1.73

Published: 2009

Journal Articles

Immune-Mediated Hemolytic Anemia

Wendell F. Rosse, Peter Hillmen, Alan D. Schreiber

Hematology Am Soc Hematol Educ Program (2004) 2004 (1): 48–62.

https://doi.org/10.1182/asheducation-2004.1.48

Published: 2004

NARROW

Immunoregulatory networks in sickle cell alloimmunization

Should the presence of an antiphospholipid antibody affect the duration of anticoagulant treatment in patients with venous thromboembolism?

Role of ADAMTS13 in the pathogenesis, diagnosis, and treatment of thrombotic thrombocytopenic purpura

The many faces of common variable immunodeficiency

What is the Benefit of Maintenance Therapy with Lenalidomide or Bortezomib after Autologous Stem Cell Transplantation in Multiple Myeloma and What is the Risk of Developing a Secondary Primary Malignancy?

ASH evidence-based guidelines: is the IgG-specific anti-PF4/heparin ELISA superior to the polyspecific ELISA in the laboratory diagnosis of HIT?

Mechanisms of anti-D action in the prevention of hemolytic disease of the fetus and newborn

Drug-induced immune hemolytic anemia

Immune-Mediated Hemolytic Anemia

ASH Publications

American Society of Hematology

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only